AMWL
American Well Corporation
AMWL's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over AMWL overall, supported by lower modeled downside and stronger modeled upside.
AMWL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
AMWL's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AMWL PE Valuation
AMWL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AMWL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMWL's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AMWL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.45 | +$3.63 |
| Q2 2026 | -$4.78 | +$3.17 |
| Q1 2026 | -$5.43 | +$4.64 |
| Q4 2025 | -$5.96 | +$7.92 |
| Q3 2025 | -$7.08 | +$7.15 |
| Q2 2025 | -$7.95 | +$13.01 |
| Q1 2025 | -$10.07 | +$14.13 |
| Q4 2024 | -$13.88 | +$33.72 |
AMWL is still losing money, but far less than before: $3.45 per share over the past year, against $81.23 at its worst in late 2020.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over AMWL on earnings quality, reporting a profit while its opponent remains loss making.
AMWL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49M | -13% |
| Q2 2026 | $52M | -27% |
| Q1 2026 | $54.9M | -18% |
| Q4 2025 | $55.3M | -22% |
| Q3 2025 | $56.3M | -7.8% |
| Q2 2025 | $70.9M | +13% |
| Q1 2025 | $66.8M | +12% |
| Q4 2024 | $71M | +0.5% |
AMWL's revenue has slid since its 2022 peak: $49M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | +28 points |
| Q2 2026 | -18% | +10 points |
| Q1 2026 | -32% | +14 points |
| Q4 2025 | -45% | +15 points |
| Q3 2025 | -52% | +26 points |
| Q2 2025 | -29% | +55 points |
| Q1 2025 | -46% | +81 points |
| Q4 2024 | -60% | +20 points |
AMWL's operating margin was −24% last quarter, up 28 points from the same quarter a year ago, near the top of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over AMWL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over AMWL on profitability, with a higher operating margin.
AMWL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.7M | +$7.1M |
| Q2 2026 | $10.7M | +$15.4M |
| Q1 2026 | -$988K | +$24.1M |
| Q4 2025 | -$17.4M | -$3.9M |
| Q3 2025 | -$18.8M | +$13.6M |
| Q2 2025 | -$4.7M | +$17.1M |
| Q1 2025 | -$25.1M | +$34.7M |
| Q4 2024 | -$13.4M | +$28.2M |
AMWL has burned cash in almost every quarter: −$19M over the past year, against −$62M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AMWL on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMWL Net Leverage
AMWL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
AMWL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 37.6 | Neutral |
AMWL's weekly RSI is 54 (neutral) and its Stochastic is 38 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AMWL PE vs Healthcare Sector
AMWL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AMWL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.6 | 4.1% below |
| 20 week MA | $12.2 | 1.4% below |
| 50 week MA | $8.53 | 41% above |
| 100 week MA | $7.98 | 51% above |
| 200 week MA | $17.1 | 30% below |
AMWL's trend is mixed: it's above two of its five weekly moving averages, and 30% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over AMWL on trend strength, trading above more of its moving averages.
AMWL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $460.4 | $595.0 | +29% |
| 2021 | $595.0 | $128.6 | -78% |
| 2022 | $128.6 | $61.6 | -52% |
| 2023 | $61.6 | $29.8 | -52% |
| 2024 | $29.8 | $7.80 | -74% |
| 2025 | $7.80 | $4.55 | -42% |
| 2026 YTD | $4.55 | $12.0 | +164% |
AMWL has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.